Patient characteristic | Total patients | Remission patients | Active patients |
---|---|---|---|
Phase I | n = 32 | n = 22 | n = 10 |
Age, y, mean ± SD | 13.8 ± 2.6 | 14 ± 2.7 | 13.4 ± 2.6 |
Range | 8–17 | 8–17 | 9–17 |
Gender, n (%) | |||
Female | 18 (56) | 12 (55) | 6 (60) |
Male | 14 (44) | 10 (45) | 4 (40) |
Race/ethnicity, n (%) | |||
Caucasian | 26 (81) | 17 (77) | 9 (90) |
African American | 3 (9) | 3 (14) | – |
Asian | 1 (3) | 1 (5) | – |
Latino/a | 2 (6) | 1 (5) | 1 (10) |
PUCAI total score, n (%) | |||
0 | 19 (59) | 19 (86) | – |
5 | 3 (9) | 3 (14) | – |
10 | 1 (3) | – | 1 (10) |
15 | 1 (3) | – | 1 (10) |
20 | 4 (13) | – | 4 (40) |
35 | 1 (3) | – | 1 (10) |
45 | 2 (6) | – | 2 (20) |
55 | 1 (3) | – | 1 (10) |
Patient characteristic | Total patients | Remission patients | Active patients |
---|---|---|---|
Phase II | n = 38a | n = 22b | n = 18b |
Age, y, mean ± SD | 12.84 ± 2.38 | 11.91 ± 2.11 | 14.06 ± 2.39 |
Median | 13 | 12 | 14 |
Range | 8–17 | 8–16 | 10–17 |
Gender, n (%) | |||
Female | 22 (58) | 12 (55) | 12 (67) |
Male | 16 (42) | 10 (45) | 6 (33) |
PUCAI total score, n (%) | n = 40a | n = 22b | n = 18b |
Average score, mean ± SD | 12.25 ± 14.36 | 1.81 ± 2.46 | 25.00 ± 12.37 |
Range | 0–45 | 0–5 | 10–45 |
0 | 14 (35) | 14 (64) | – |
5 | 8 (20) | 8 (36) | – |
10 | 4 (10) | – | 4 (22) |
15 | 2 (5) | – | 2 (11) |
20 | 2 (5) | – | 2 (11) |
25 | 4 (10) | – | 4 (22) |
35 | 2 (5) | – | 2 (11) |
40 | 2 (5) | – | 2 (11) |
45 | 2 (5) | – | 2 (11) |